SCHEMBL26912286

SCHEMBL26912286

Cc1ccc(S(=O)(=O)n2ccc3c(OCc4ccccc4)cc(Cl)c(Cl)c32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFD P00746 1/20 0.45
▸ HTR6 P50406 4/20 0.41
▸ BCHE P06276 2/20 0.41
▸ PSEN1 P49768 2/20 0.41
▸ PSEN2 P49810 2/20 0.41
▸ APH1B Q8WW43 2/20 0.41
▸ NCSTN Q92542 2/20 0.41
▸ APH1A Q96BI3 2/20 0.41
▸ PSENEN Q9NZ42 2/20 0.41
▸ CYP19A1 P11511 1/20 0.40
▸ LMNA P02545 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ KEAP1 Q14145 1/20 0.40
▸ NFE2L2 Q16236 1/20 0.40
▸ CD4 P01730 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26912212 0.83 MEN1 (0.40) HTR6BCHEBRD4MEN1KMT2A
SCHEMBL26913094 0.82 ALDH1A1 (0.39) HTR6BCHECYP3A4MAPTCYP2C9
SCHEMBL26912343 0.82 BRD4 (0.38) CFDHTR6BCHEALDH1A1BRD4
SCHEMBL26912802 0.78 BRD4 (0.37) HTR6POLBKDM4EALDH1A1BRD4
SCHEMBL26912858 0.77 MEN1 (0.37) HTR6BCHEPOLBBRD4MEN1
SCHEMBL26913110 0.77 BRD4 (0.36) HTR6BCHEPOLBBRD4MEN1
SCHEMBL26913211 0.77 BRD4 (0.36) HTR6KDM4EALDH1A1BRD4MEN1
SCHEMBL28694315 0.75 L3MBTL1 (0.52) CFDHTR6BCHECYP19A1LMNA
SCHEMBL30644824 0.75 L3MBTL1 (0.52) CFDHTR6BCHECYP19A1LMNA
SCHEMBL26913012 0.75 BRD4 (0.35) HTR6LMNAKDM4EBRD4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391786-A1 cGAS INHIBITORS ELI LILLY AND COMPANY 2023-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391786-A1 cGAS INHIBITORS CGAS, STING1, TBK1 CFD 4551/4885HTR6 2549/4885BCHE 2960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback